ABSTRACT: There have been several sustained-release materials containing anti-tuberculosis drug to enhance concentration in foci of spinal tuberculosis but what map by which composite drug delivery system is released is not known. Isoniazid (INH) lactic-co-glycolic acid (PLGA) and INH hydroxyapatite (HA) microspheres were prepared, respectively. The rabbits were modeled by tuberculosis strains and sustained-release microspheres were incubated in the foci. INH concentrations in the HA group were higher than those of INH and PLGA groups at L3, L4, and L5 vertebra 2 days after the drugs were embedded (p < 0.05). INH concentrations in the HA group were higher than those of INH and PLGA groups in L3 vertebra 4 days after the drugs were embedded (p < 0.05). INH concentrations in the PLGA group were higher than those of INH and HA groups in L5 vertebra; INH concentrations of the HA group were higher than those of INH and PLGA groups in L4 vertebra 6 days after the drugs were embedded (p < 0.05). These microspheres can enhance INH concentration in the foci. Furthermore, HA microspheres elicit osteogenic effects. HA is better than PLGA in terms of infiltration, but PLGA is better than HA in terms of distribution. ß
Tuberculosis (TB) is a potentially fatal contagious disease caused by Mycobacterium tuberculosis. Musculoskeletal involvement in TB has also been reported in approximately 3-5% of human immunodeficiency virus (HIV)-negative patients and 60% of HIV-positive patients after these patients suffer from pulmonary infection. 1 Although TB incidence is high in some groups, this incidence is higher in developing countries because of population growth, poor socio-economic conditions, and political instability than in developed countries. The number of TB cases in Western countries has also increased because of HIV epidemic, immigration, and drug resistance.
TB foci can be directly resected with surgery; however, TB bacteria are unresectable. M. tuberculosis is easily absorbed as residue in patients who underwent internal fixation. 2, 3 In addition to unique composition and physiological activity of bones, the half-life of anti-TB drugs (ATDs) is shorter than that of other drugs, and the organization permeability of ATDs is weak; as such, ATDs cannot be easily and efficiently transported to lesion sites when conventional methods are used. 4, 5 These factors have resulted in post-operative recurrence of spinal TB. Therefore, medications compounded with ATDs are routinely applied to lesion sites to complete surgery and to kill local residual tubercle bacilli.
Polylactic acid (PLA) has been widely used in experimental studies on drug delivery systems. [6] [7] [8] Among these systems, poly (lactic-co-glycolic acid) (PLGA) has been approved by the FDA as a medical material used in microcapsules, microspheres, implants, sustained-release preparations, and injections to prevent film material adhesion. 9, 10 The composition and structure of hydroxyapatite (HA) is similar to the inorganic composition of hard tissues (such as bones and teeth) of human. HA exhibits excellent biological compatibility and biological activity; therefore, HA can be combined with original bone displaying normal physiological characteristics. 11, 12 The two kinds of sustained-release materials have been used in spinal TB to improve local tissue drug concentration. However, the retention of ATDs concentration in vivo, particularly on a long term, remains unknown. Therefore, this study aimed to re-design two kinds of lowrelease agents with good compatibility for ATDs transport. High-performance liquid chromatographymass spectrometry (HPLC-MS) was applied to determine ATDs concentrations in lesion sites and adjacent segment osseous tissues to understand the map by which composite drug delivery system is released in vivo; thus, a comprehensive mapping of distribution law of the two kinds of controlled release ATDs systems can be obtained.
MATERIALS AND METHODS
Preparation of PLGA Microspheres Isoniazid (INH) PLGA microspheres were prepared using double emulsion/solvent evaporation method. 13 Polyvinyl alcohol was weighed to obtain 4 and 1 g; afterward, 100 ml of ultrapure water was added to each amount of polyvinyl alcohol. The resulting solution was heated and fully agitated at 100˚C to obtain 4% and 1% polyvinylchloride (PVC) water, respectively. INH weighing 20 mg was dissolved in 1 m of 4% PVC water. PLGA (levolactic acid/glycolic acid ¼ 50:50, 100,000 Da) weighing 25 mg was dissolved in 2 ml of dichloromethane. Then, 4% PVC water with INH was added to 2 ml of dichloromethane and magnetically stirred in an ice bath for 1 min to obtain water/oil components. Approximately 10 ml of 1% PVC water was added and magnetically stirred for 10 min to obtain water/oil/water components, which were then added to 20 ml of 1% PVC water and stirred for 12-18 h. The liquid was centrifuged at 4,000 rpm for 10 min; white flotation particles with a porosity of 63.68% and an average diameter of 200 mm were obtained (Fig. 1A-D) .
Preparation of Polyporous HA Microspheres INH HA microspheres were prepared using vacuum infiltration technique.
14 The components (Li 2 CO 3 , CaCO 3 , H 3 BO 3 ¼ 10:10:80) were thoroughly stirred, placed in a silicon carbide furnace, heated at 1,100˚C for 15 min until these components completely melted, and rapidly quenched in an ice bath. Afterward, the parcels were sifted through 100-and 140-mesh sieves, collected, and nodulized in a tubular furnace twice. The parcels were added to K 2 HPO 4 solution (0.25 mol/L, pH ¼ 9) and placed in an oven at 37˚C for 1 week. The parcels were flushed with deionized water and then dried at 90˚C for 24 h. The dried parcels were subsequently placed in a muffle furnace and heated at 800˚C for 2 h; porous microspheres with a porosity of 82.18% and an average diameters of 10 mm were obtained. INH (23.4 mg) was added to 1 ml of ultrapure water. HA microsphere (0.1 g) was vacuum-dried in an oven (<0.058 MPa) for 12 h to remove gas in pores and to increase drug loading (Fig. 1E-H ).
Histocompatibility and Release of Two Kinds of Controlled Release Microspheres
Two microspheres, 375.66 mg of PLGA microspheres and 956.94 mg of HA microspheres, were weighed (contained 100 mg of INH, respectively). These microspheres were placed in a dialysis bag and 5 ml of PBS (pH 7.4) was added. 
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INH (100 mg) was treated in the same manner as the control group. The dialysis bag was sealed, placed in a bottle with 20 ml of PBS, and subjected to thermostatic incubation at 37˚C. Afterward, 20 ml of PBS was aspirated at 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44 , 48, and 52 days to detect drug concentration and histocompatibility. Rat osteoblasts of the three groups were cultured in PBS to detect histocompatibility by using alkaline phosphatase (ALP) activity and calcium nodule staining (Fig. 2 ).
15-17
Establishment of a Spinal TB Animal Model Experimental Animal Preparation Thirty-six clean-grade New Zealand white rabbits with half males and half females aged 2-3 years (Guangdong Province Animal Centre) were selected. Dexamethasone was injected every other day (0.16 mg/kg) for 1 week and then orally administered daily (0.03 mg/kg) to inhibit humoral and cellular immunity of rabbits. The approval from the institutional review board of the Southern Medical University was obtained.
Strain Preparation
Mycobacterium bovis bacillus Calmette-Gu erin (BCG) strains were cultured in modified Sauton liquid and subjected to amplification for 2-3 weeks. The strains were placed in centrifuge tubes, centrifuged at 1,200 rpm for 20 min, and diluted with 10% calf serum at room temperature to obtain adqulis bacterium suspension (5 mg/ml); the suspension was diluted again and adjusted to 1 Â 10 5 CFU/ml under a microscope.
Strain Inoculation
Posterior approach was used to inoculate the rabbits with medical gelatin sponge containing 0.1 ml of BCG suspension liquid. The modeled rabbits were divided into three groups, and each group comprised 12 rabbits. The rabbits were orally administered with INH (10 mg/kg), rifampicin (20 mg/kg), pyrazinamide (30 mg/kg), ethambutol (15 mg/kg), and streptomycin (20 mg/kg) to simulate clinical chemotherapy. After 2 months the same method was used to incubate sustained-release microspheres or INH in the same place (L5 vertebral body) in the second surgery. The placed volume of INH and microspheres for controlled release was converted into containing 10 mg of INH. Eight rabbits were sacrificed at each time point (1, 2, 4, and 8 weeks) and the other rabbits were sacrificed at 2, 4, 6, and 8 days, respectively, in each group to obtain osseous tissue samples used to detect the ATD concentrations.
Determination of ATD Concentrations
The preparation of sample was same to our previous research. 4 The chromatographic column was a hydrophilic HPLC measuring 150Â 2.1 mm 2 i.d., and 3 mm (Thermo, Waltham, 
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Statistical Analysis Differences of means within groups were evaluated statistically by one-way ANOVA version 13.0 (SPSS UK Ltd., Woking, United Kingdom) with Dunnett-T3 post hoc. p < 0.05 was considered as a significant level.
RESULTS
Histocompatibility of Two Kinds of Controlled ATD Release Systems
The ALP dyeing color of HA group was stronger than that of PLA and control groups. However, ALP dyeing color was similar between PLA and control groups. The number of osteoblasts in the HA group was higher than that of PLA group or control group at 14 and 22 days after cell culture.
Characterization of Sustained-Release Carrier of ATDs
The two types of microspheres can release sufficient INH higher than the effective bactericidal concentration (0.05 mg/ml) in 52 days in vitro (Fig. 4) .
Characterization of Experimental Animal Models
The morphological characteristics of experimental animal bone tissue evidently changed after the model was established. Partial necrosis and inflammation 
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associated with basophil and leukocyte infiltration occurred in 1-2 weeks. Granulation and scar tissue were produced during 4-8 weeks. There were some similarities between the local histological changes and typical tuberculous granuloma. 19 Changes in the osseous tissue surrounding the hole were not apparent within 1-2 weeks, but bone slightly eroded in 4-8 weeks (Fig. 5) .
Concentration of ATDs in the Lesion and Surrounding
Tissue INH concentrations did not significantly differ between the INH and the PLGA group in experimental animal lesions 1 week after the drugs were embedded (p > 0.05); by contrast, the INH significantly differed from the HA group (p < 0.05). In the INH group, INH concentrations decreased 2 weeks after the drug was embedded; this concentration was less than that of PLGA and HA groups 4 weeks after the drugs were embedded (p < 0.05). After 4 weeks, INH concentrations in experimental animal lesions of the HA group were less than those of the PLGA group (p < 0.05; Tables 1  and 2 ). INH concentrations in the HA group were higher than those of INH and PLGA groups at L3, L4, and L5 vertebra 2 days after the drugs were embedded (p < 0.05). INH concentrations in the PLGA group were higher than those of INH and HA groups in L4 and L5 vertebra; INH concentrations in the HA group were higher than those of INH and PLGA groups in L3 vertebra 4 days after the drugs were embedded (p < 0.05). INH concentrations in the PLGA group were higher than those of INH and HA groups in L5 vertebra; INH concentrations of the HA group were higher than those of INH and PLGA groups in L4 vertebra 6 days after the drugs were embedded (p < 0.05). INH concentrations in the PLGA group were higher than those of INH and HA groups in L5 vertebra 8 days after the drugs were embedded (Fig. 6 ).
DISCUSSION
TB has been considered as a recurring disease; TB has also been ranked second only to HIV/AIDS in causing death induced by single infectious agent. 20 TB accounts for approximately 1.7 million deaths each year, and the number of new cases (more than nine million) worldwide continuously increases. 21 Osteoarticular TB cases account for approximately 10-11% of extrapulmonary TB cases. [22] [23] [24] [25] [26] [27] Composite biomaterial scaffolds releasing ATDs into spinal lesions have been extensively investigated to improve local drug concentrations. [28] [29] [30] [31] [32] However, the release of composite scaffold drug delivery systems in vivo remains unknown, particularly the penetration of such systems to surrounding tissues of lesions. In this study, two kinds of common composite scaffold drug delivery systems were successfully prepared and experimental animals were modeled using BCG strains to simulate pathological changes in spinal TB. HPLC-MS was performed to detect ATD concentration in spinal TB foci and adjacent intervertebral disc tissue. The two composite scaffold drug delivery systems were subjected to histocompatibility evaluation before use to ensure that these systems unlikely caused damage to organisms. Polypore HA microspheres were also evaluated through a comparative test to determine additional osteogenic effects. The two controlled ATD release systems differed in vivo and in vitro. INH release in the HA group was higher than that of the PLGA group at 12 days in vitro; on the contrary, INH release in the HA group was lower than that of the PLGA group after 12 days. The difference in INH release in vivo between the two groups was observed within 7 days. This difference may be related to temperature, pH, and metabolites in the foci in vivo.
Considering ATD concentration in the foci, we observed that the HA group differed from PLGA and INH groups. Significant differences were observed 2 and 4 weeks after inoculation was performed; conversely, no significant difference was observed between HA and PLGA groups 8 weeks after inoculation was performed. This release also differed from in vitro release. ATD concentrations of the PLGA group were slightly and significantly higher than those of the HA There are some limitations in the study. BCG, an attenuated M. bovis strain, has been used in animal models to investigate human TB. 33, 34 BCG differs from H37R V (a normal M. tuberculosis strain) in terms of the morphological characteristics of animal models, but immune response of organisms to BCG is not less than the response to H37R V . 35 However, our study did not include the immune system; our study is also limited by experimental conditions because BCG is relatively safe in terms of contagiousness. Furthermore, disease course differs between animal and patient models. TB is a chronic disease, and patients mainly suffer from this disease for more than 2 years; experimental animal models are prepared with time intervention of approximately 8 weeks. Therefore, changes in local lesions of patients with spinal TB undergo hyperplasia or metamorphism; conversely, animal models exhibit changes maybe in exudative stage and in serous or serofibrinous inflammation. Spinal TB is a chronic illness and easily caused by irregular and incomplete chemotherapy. 36 These conditions cause local plasma fibrin precipitation until calcification occurs, thereby producing lesions; a sclerotic wall is eventually found around lesions. This situation is very difficult to simulate under experimental conditions. Nonetheless, the bone tissue of experimental animals exhibited morphological changes after the model was established. Figure 5C and D shows that a large number of lymphocytes infiltrated the foci and granulation tissue composed of fibroblasts around these lymphocytes. Lesions of bone trabecula and bits of tissue macrophages formed. Undoubtedly, tissue macrophages could be translated into epithelioid cells under certain conditions, and epithelioid cells could be further integrated into Langerhans cells. A typical tuberculous granuloma is composed of epithelioid cells, Langerhans cells, and caseous necrosis.
CONCLUSION
After INH distributed by a low-release agent was incubated, INH infiltrated adjacent tissues in the PLGA group, and this infiltration was relatively weaker than that in the HA group. INH infiltrated one adjacent intervertebral disc in the HA group after this substance was incubated in vertebral osseous tissues after 2-4 days; INH concentration was higher than the MIC of INH after 6-8 days. INH also infiltrated two, one, and one adjacent vertebrae in the HA group after 2, 4, and 6 days, respectively. INH infiltrated one adjacent vertebra in the PLGA group after 4-6 days. After 8 days, INH concentration in adjacent vertebrae decreased below the MIC of INH in the HA and PLGA groups; however, INH concentration in the HA group was higher than that of the PLGA group. Therefore, HA is better than PLGA in terms of infiltration, but PLGA is better than HA in terms of distribution.
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